Literature DB >> 24712464

Functional dynamics of Foxp3⁺ regulatory T cells in mice and humans.

Khalid Bin Dhuban1, Mara Kornete, Edward S Mason, Ciriaco A Piccirillo.   

Abstract

Forkhead box protein 3 (Foxp3)(+) regulatory T (Treg) cells are critical mediators for the establishment of self-tolerance and immune homeostasis and for the control of pathology in various inflammatory responses. While Foxp3(+) Treg cells often control immune responses in secondary lymphoid tissues, they must also traffic to and persist within non-lymphoid tissues, where they integrate various environmental cues to coordinate and adapt their effector acitvities in these sites. In recent years, our group has made use of several mouse models, including the non-obese diabetic model of type 1 diabetes, to characterize the factors, which impact the homeostasis, function, and reprogramming potential of Foxp3(+) Treg cells in situ. In addition, our recent work shows that Foxp3(+) Treg cells possess distinct post-transcriptional mechanisms of gene regulation, namely mRNA translation, to modulate tissue-specific inflammatory responses. In humans, there is a pressing need for reliable markers of FOXP3(+) Treg cells and their related function in blood and tissue. Experimental progress in our group has enabled us to discover novel markers of FOXP3(+) Treg cell (dys)function and unique gene signatures that discriminate effector and Treg cells, as well as functional and dysfunctional FOXP3(+) Treg cells.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Foxp3; autoimmunity; infections; regulatory T cells; tolerance

Mesh:

Substances:

Year:  2014        PMID: 24712464     DOI: 10.1111/imr.12168

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  20 in total

Review 1.  Recent advances in CD8+ regulatory T cell research.

Authors:  Yating Yu; Xinbo Ma; Rufei Gong; Jianmeng Zhu; Lihua Wei; Jinguang Yao
Journal:  Oncol Lett       Date:  2018-03-29       Impact factor: 2.967

Review 2.  Dipeptidyl peptidase-4(DPP-4) inhibitors: promising new agents for autoimmune diabetes.

Authors:  Xia Wang; Peilin Zheng; Gan Huang; Lin Yang; Zhiguang Zhou
Journal:  Clin Exp Med       Date:  2018-07-17       Impact factor: 3.984

3.  Regulatory cells in health and disease.

Authors:  Andrew J Caton; Katherine A Weissler
Journal:  Immunol Rev       Date:  2014-05       Impact factor: 12.988

4.  BET Bromodomain Inhibition Cooperates with PD-1 Blockade to Facilitate Antitumor Response in Kras-Mutant Non-Small Cell Lung Cancer.

Authors:  Dennis O Adeegbe; Shengwu Liu; Maureen M Hattersley; Michaela Bowden; Chensheng W Zhou; Shuai Li; Raven Vlahos; Michael Grondine; Igor Dolgalev; Elena V Ivanova; Max M Quinn; Peng Gao; Peter S Hammerman; James E Bradner; J Alan Diehl; Anil K Rustgi; Adam J Bass; Aristotelis Tsirigos; Gordon J Freeman; Huawei Chen; Kwok-Kin Wong
Journal:  Cancer Immunol Res       Date:  2018-08-07       Impact factor: 11.151

5.  Categorical Analysis of Human T Cell Heterogeneity with One-Dimensional Soli-Expression by Nonlinear Stochastic Embedding.

Authors:  Yang Cheng; Michael T Wong; Laurens van der Maaten; Evan W Newell
Journal:  J Immunol       Date:  2015-12-14       Impact factor: 5.422

6.  Enhancement of scutellarin oral delivery efficacy by vitamin B12-modified amphiphilic chitosan derivatives to treat type II diabetes induced-retinopathy.

Authors:  Jingnan Wang; Jiayun Tan; Jiahao Luo; Peilin Huang; Wuyi Zhou; Luming Chen; Lingli Long; Li-Ming Zhang; Banghao Zhu; Liqun Yang; David Y B Deng
Journal:  J Nanobiotechnology       Date:  2017-03-01       Impact factor: 10.435

Review 7.  Transcriptional regulation and development of regulatory T cells.

Authors:  Wonyong Lee; Gap Ryol Lee
Journal:  Exp Mol Med       Date:  2018-03-09       Impact factor: 8.718

Review 8.  Induction of Regulatory T Cells by Intravenous Immunoglobulin: A Bridge between Adaptive and Innate Immunity.

Authors:  Gabriel N Kaufman; Amir H Massoud; Marieme Dembele; Madelaine Yona; Ciriaco A Piccirillo; Bruce D Mazer
Journal:  Front Immunol       Date:  2015-09-11       Impact factor: 7.561

9.  Analyses of regulatory CD4+ CD25+ FOXP3+ T cells and observations from peripheral T cell subpopulation markers during the development of type 1 diabetes in children.

Authors:  S Hamari; T Kirveskoski; V Glumoff; P Kulmala; O Simell; M Knip; R Veijola
Journal:  Scand J Immunol       Date:  2016-04       Impact factor: 3.487

Review 10.  Therapeutic application of T regulatory cells in composite tissue allotransplantation.

Authors:  Jeong-Hee Yang; Seok-Chan Eun
Journal:  J Transl Med       Date:  2017-10-26       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.